UpDoc
PrivateLast Round
Seed
Jun 25, 2026
Total Funding Raised
$18M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
UpDoc operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Seed round in June 2026.
UpDoc is a healthcare technology company developing a conversational AI platform that manages medication prescriptions and chronic disease.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Patient Engagement, Telemedicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UpDoc Comparables
Compare UpDoc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atman Health | 87% | |
| Clinii | 74% | |
| Welldoc | 70% |
For institutional investors. Book with your work email.
UpDoc Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
UpDoc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Seed |
| Pear VC | Seed |
| Polaris Partners | Seed |
| Oxeon Partners | Seed |
| Cathay Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Open roles increased to 21, 111% of headcount.
- Sep 7, 2026
Open roles increased to 14, representing 78% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 11, 2026
UpDoc, Inc. plans to develop a patient-facing agentic system that supports patients with heart failure between visits and escalates to their care team.
- signs_new_clientSep 9, 2026
UpDoc, Inc. signs ARPA-H as a new client after being selected as a lead performer in the ADVOCATE program to develop and validate an autonomous cardiovascular clinical AI system, with an award of up to $9.2 million, in California on Sep 9th '26.
For institutional investors. Book with your work email.
UpDoc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about UpDoc's valuation, stock price, and market status.
Is UpDoc a public or private company?
UpDoc is a private company.
What is the current stock price of UpDoc?
UpDoc is a private company, so its shares have no public market price. Caplight tracks UpDoc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is UpDoc worth (valuation)?
Valuation information for UpDoc is not publicly available.
Can I buy UpDoc stock?
UpDoc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was UpDoc's last funding round?
UpDoc's most recent funding round was Seed on June 25, 2026.
Who are the main investors in UpDoc?
Key investors in UpDoc include Polaris Partners.
Will UpDoc IPO soon?
No public IPO plans have been announced for UpDoc.
How can I track UpDoc secondary market activity?
Caplight tracks bids, offers, and trades in UpDoc's shares on secondary markets.